Development or improvement of clinical diagnostic tests for sars-COV-2 to increase the sensitivity, specificity and ability to provide rapid results…
Ended Project Grant Awarded Last action
- Award ID
- R01AI158068
- Recipient
-
Pathogendx Inc. UEI F5MNXH19HA55
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,594,471
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $1,835,191.53 Federal
- $759,279.00 Non-federal
- Place of performance
- Tucson, AZ 85714, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$475 | $0 | |
| Amendment | $574,239 | $0 | |
| Amendment | $574,239 | $574,239 | |
| Amendment | $185,040 | $0 | |
| Amendment | $185,040 | $185,040 | |
| Original award | $317,109 | $0 |
Quick answers
Who received award R01AI158068?
R01AI158068 was awarded to Pathogendx Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 11, 2020.
How much is award R01AI158068 worth?
$2,594,471 has been obligated on R01AI158068: $1,835,192 in federal funding and $759,279 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award